AIP
INFI

Ameritas Investment Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Ameritas Investment Partners’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,863
Closed -$8K – 3313
2022
Q1 		$8K Hold
6,863
– – ﹤0.01% 2873
2021
Q4 		$15K Hold
6,863
– – ﹤0.01% 2772
2021
Q3 		$23K Hold
6,863
– – ﹤0.01% 2633
2021
Q2 		$21K Buy
+6,863
New +$21.7K ﹤0.01% 2723
2017
Q2 		– Sell
-4,129
Closed -$13K – 3067
2017
Q1 		$13K Buy
+4,129
New +$10.2K ﹤0.01% 2616

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Ameritas Investment Partners's INFI Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 6,863 shares — an estimated $8K sold.

Ameritas Investment Partners first reported a position in INFI in Q1 2017 and held it in 5 quarters. The position peaked at $23K in Q3 2021. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • Ameritas Investment Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 6,863 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $8K.
  • Ameritas Investment Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2017 and held it in 5 quarters.
  • Ameritas Investment Partners's Infinity Pharmaceuticals, Inc. position peaked at $23K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.